BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burghardt KJ, Seyoum B, Dass SE, Sanders E, Mallisho A, Yi Z. Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. Pharmacotherapy 2018;38:428-35. [PMID: 29484683 DOI: 10.1002/phar.2097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Micale V, Di Bartolomeo M, Di Martino S, Stark T, Dell'osso B, Drago F, D'addario C. Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. Pharmacology & Therapeutics 2022. [DOI: 10.1016/j.pharmthera.2022.108279] [Reference Citation Analysis]
2 Burghardt KJ, Calme G, Caruso M, Howlett BH, Sanders E, Msallaty Z, Mallisho A, Seyoum B, Qi YA, Zhang X, Yi Z. Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers. Brain Sciences 2022;12:259. [DOI: 10.3390/brainsci12020259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Howlett BH, Kassa MA, Burghardt KJ. DNA methylation in bipolar disorder. Biomarkers in Bipolar Disorders 2022. [DOI: 10.1016/b978-0-12-821398-8.00010-2] [Reference Citation Analysis]
4 Ward KM, Burghardt K, Kraal AZ, Jaeger A, Yeomans L, McHugh C, Karnovsky A, Stringer KA, Ellingrod VL. Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics. Front Psychiatry 2021;12:623143. [PMID: 34113268 DOI: 10.3389/fpsyt.2021.623143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhou J, Li M, Wang X, He Y, Xia Y, Sweeney JA, Kopp RF, Liu C, Chen C. Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. Front Neurosci 2021;15:674273. [PMID: 34054421 DOI: 10.3389/fnins.2021.674273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
6 Lima CN, Salarda EM, Pinjari OF, Fries GR. Epigenetics of bipolar disorder. Epigenetics in Psychiatry 2021. [DOI: 10.1016/b978-0-12-823577-5.00025-8] [Reference Citation Analysis]
7 Lima CNDC, Pink O, Fries GR. Epigenetic mechanisms of bipolar disorder. Neurobiology of Bipolar Disorder 2021. [DOI: 10.1016/b978-0-12-819182-8.00018-1] [Reference Citation Analysis]
8 Huang J, Chen Z, Zhu L, Wu X, Guo X, Yang J, Long J, Su L. Phosphoinositide-3-kinase regulatory subunit 1 gene polymorphisms are associated with schizophrenia and bipolar disorder in the Han Chinese population. Metab Brain Dis 2020;35:785-92. [DOI: 10.1007/s11011-020-00552-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Burghardt KJ, Khoury AS, Msallaty Z, Yi Z, Seyoum B. Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review. Pharmacotherapy 2020;40:331-42. [PMID: 32058614 DOI: 10.1002/phar.2375] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
10 Grajales D, Ferreira V, Valverde ÁM. Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain. Cells 2019;8:E1336. [PMID: 31671770 DOI: 10.3390/cells8111336] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 16.0] [Reference Citation Analysis]
11 Burghardt KJ, Howlett BH, Sanders E, Dass SE, Msallaty Z, Mallisho A, Seyoum B, Yi Z. Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder. Eur Neuropsychopharmacol 2019;29:1365-73. [PMID: 31635791 DOI: 10.1016/j.euroneuro.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Cacabelos R, Carril JC, Sanmartín A, Cacabelos P. Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics. Pharmacoepigenetics. Elsevier; 2019. pp. 191-424. [DOI: 10.1016/b978-0-12-813939-4.00006-1] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Burghardt KJ, Ward KM, Sanders EJ, Howlett BH, Seyoum B, Yi Z. Atypical Antipsychotics and the Human Skeletal Muscle Lipidome. Metabolites 2018;8:E64. [PMID: 30322152 DOI: 10.3390/metabo8040064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]